Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Cytochrome P-450 CYP2C9 MeSH Descriptor Data 2025


MeSH Heading
Cytochrome P-450 CYP2C9
Tree Number(s)
D08.244.453.491.500.500
D08.811.682.690.708.170.450.500.500
D12.776.422.220.453.491.500.500
Unique ID
D065729
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D065729
Scope Note
A cytochrome P-450 subtype that has specificity for acidic XENOBIOTICS. It oxidizes a broad range of important clinical drugs that fall under the categories of NONSTEROIDAL ANTI-INFLAMMATORY AGENTS; HYPOGLYCEMIC AGENTS; ANTCOAGULANTS; and DIURETICS.
Entry Term(s)
CYP2C9
CYPIIC9
Cytochrome P450 MP-4
Cytochrome P450 MP-8
Cytochrome P450 PB-1
Registry Numbers
EC 1.14.13.-
Previous Indexing
*Aryl Hydrocarbon Hydroxylases (2003-2014)
Public MeSH Note
2015
History Note
2015
Entry Combination
antagonists & inhibitors:Cytochrome P-450 CYP2C9 Inhibitors
Date Established
2015/01/01
Date of Entry
2014/06/26
Revision Date
2016/05/27
Cytochrome P-450 CYP2C9 Preferred
page delivered in 0.147s